Where the Money Goes

Fred Hutch counts on Obliteride fundraising — and our sponsors ensure that 100% of every dollar you raise helps us advance cancer prevention, detection, treatment, and cures. In the last 11 years, we’ve fueled new approaches for breast, colon, pancreatic and prostate cancer; breakthroughs in data science; community partnerships that improve health; novel therapies that retrain the body’s immune cells to attack cancers; and powerful insights into diet, genetics, environmental factors, and cancer risk.

About Fred Hutch

Fred Hutchinson Cancer Center unites individualized care and advanced research to provide the latest cancer treatment options while accelerating discoveries that prevent, treat and cure cancer and infectious diseases worldwide.

Based in Seattle, Fred Hutch is an independent, nonprofit organization and the only National Cancer Institute-designated cancer center in Washington. We have earned a global reputation for our track record of discoveries in cancer, infectious disease and basic research, including important advances in bone marrow transplantation, immunotherapy, HIV/AIDS prevention and COVID-19 vaccines. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services. Fred Hutch also serves as UW Medicine’s cancer program.

Fred Hutchinson Cancer Center is an independent, nonprofit organization that also serves as the cancer program for UW Medicine. Our relationship allows for enhanced care coordination between a top-ranked cancer center and a leading integrated health system and accelerates the latest scientific breakthroughs in cancer and other life-threatening diseases.  

Fred Hutch is proud to raise funds that fuel the adult oncology program on behalf of both Fred Hutch and UW Medicine.

UW Medicine logo

Obliteride Matters: Our Impact

Dollars from Obliteride power Fred Hutch’s most innovative work. Whether our participants chose to fundraise for our areas of greatest need, a specific disease area, a researcher, or a program, 100% of their fundraising fuels advances in lifesaving research and compassionate care.

Partnering for Cures: Areas of Greatest Need

This season, many Obliteriders chose to raise funds for Fred Hutch’s areas of greatest need. This support allows us to be agile and responsive. It speeds research by allowing our scientists to quickly follow where science leads. It allows us to hire the best minds and support their most promising ideas. And it advances supportive care programs that patients need to thrive. We’re honored to have earned the trust of our community as we work together to bring advances in prevention, detection, treatment, and cures to all who need them.

Passion and Action: Specific Disease Areas

In 2023, passionate Obliteriders also fundraised for the cancers or disease areas that were most meaningful to them. Their fundraising supports Fred Hutch scientists, clinicians, and staff working at the leading edge of their fields to advance new options for people experiencing cancer and infectious diseases.


Disease areas supported

Disease areas selected:

Acute Lymphoblastic Leukemia (ALL)
Acute Myeloid Leukemia (AML)
Bladder-Urologic Cancer
Breast Cancer
Cervical Cancer
Colon Cancer
COVID-19 Virus and Vaccine Research
Esophageal Cancer
Gastrointestinal Cancers

Gynecologic Cancers
Hematologic Cancers
HIV Virus and Vaccine Research
Infectious Disease Research
Kidney/Renal Cancer
Lung Cancer

Multiple Myeloma
Neuroendocrine Tumors
Neurologic Cancers
Ovarian Cancer
Pancreatic Cancers
Prostate Cancer
Thoracic, Head, and Neck Cancers

A doctor looking at test results with her patient.

Breast Cancer

Fred Hutch’s multidisciplinary team works urgently — and hand-in-hand with people diagnosed with breast cancer — to strengthen prevention, advance diagnostic tools, improve the accuracy and safety of surgery and therapy, understand and stop metastasis, and improve care and quality of life during and after treatment.

Advancing Discovery: People

Fred Hutch researchers, clinicians, and staff are tireless innovators who are known for their rich collaborations across disciplines. Generous participant support helps them push limits and make new discoveries.


Faculty and clinicians supported

Experts selected:

James V. Alvarez, PhD
Frederick Appelbaum, MD
Alice Berger, PhD
Shailender Bhatia, MD
Jonathan B. Bricker, PhD
Susan Bullman, PhD
Paul A Carpenter, MD, MBBS
Aude G. Chapuis, MD
Delphine Chen, MD
Eric Chow, MD, MPH
Laura Connelly-Smith, MD
Larry Corey, MD
Andrew L. Coveler MD
Andrew J. Cowan, MD
H. Joachim Deeg, MD
Keith David Eaton MD, PhD
Denise Galloway, PhD
Cyrus Ghajar, PhD

Leslie Goo, PhD, MPH
Ajay K. Gopal, MD
Heather Greenlee, ND, PhD, MPH
Gavin Ha, PhD
Evan T. Hall, MD
Holly Harris, MPH, ScD
Jessica E. Hawley, MD, MS
Paul C. Hendrie, MD, PhD
David Hockenbery, MD
Eric Holland, MD, PhD
Michael Jensen, MD
Hans-Peter Kiem, MD, PhD
Sita Kugel, PhD
Johanna Lampe, PhD, RD
Hannah M. Linden MD
Keith Loeb, MD, PhD
Elizabeth Loggers, MD, PhD
Mignon Lee-Cheun Loh, MD

Julie McElrath, MD, PhD
Smitha P. Menon, MD
Soheil Meshinchi, MD, PhD
Harveshp Mogal, MD, MS, FACS, DABS, FSSO
Behnam Nabet, PhD
Peter Nelson, MD
Yaw A. Nyame, MD, MS, MBA
Johnnie José Orozco, MD, PhD
Julie Overbaugh, PhD
Venu G. Pillarisetty, MD, FACS
Christina Poh, MD
Jerald Radich, MD
Cristina P. Rodriguez, MD
Jonathan Sham, MD, MBEE
Veena Shankaran MD
Megan J. Shen, PhD
Roland Strong, PhD
Brian Till, MD

Johanna Lampe, PhD, RD

Johanna Lampe, PhD, RD

How does our diet affect cancer risk? Dr. Lampe, an experimental nutritionist and researcher at Fred Hutch and a research professor at the University of Washington School of Public Health, studies obesity, the gut microbiome and inflammation. Through studies across racial and ethnic groups, she and her team are making new discoveries about the relationship between our bodies, what we eat, and cancer risk.

Excellence and Innovation: Programs and Specialties

Fred Hutch addresses the impact of cancer and other diseases from every angle. From collaborative research and patient support to improving health equity, participant fundraising for programs and specialties helps us do more for more people.


Programs and specialties supported

Programs and specialties selected:

Basic Science
Breast Surgery
Cancer Prevention and Early Detection
Cancer Research
Cook for Your Life
Cord Blood Research
Data Science

Diversity, Equity and Reduction of Health Disparities
Evergreen Fund
HICOR (Hutchinson Institute for
     Cancer Outcomes Research)
Long-Term Follow-Up
Office of Community Outreach & Engagement

Patient and Family Assistance Fund
Patient Housing
Pete Gross House
Radiation Oncology
Science Education Partnership
Supportive Care Services
Survivorship Program

Two providers talk with a patient at a desk.

Patient and Family Assistance Fund

A cancer diagnosis often brings new financial stressors to patients and their families. This fund, sustained through generous donations (including Obliteride support), provides supplemental financial assistance for lodging, food, and fuel, helping to offset expenses in other areas of life for eligible patients.

Diversity, Equity & Inclusion

Fred Hutch’s Commitment to Diversity

Lifesaving research demands more than innovation and dedication. It requires curiosity, creativity, and fresh and varied perspectives. That’s why diversity is a core Fred Hutch value that is integral to our work.

Land Acknowledgment

Fred Hutchinson Cancer Center acknowledges the Coast Salish peoples of this land, the land which touches the shared waters of all tribes and bands within the Duwamish, Puyallup, Suquamish, Tulalip and Muckleshoot nations.

Obliteride Is for Everyone!

Take action to help cure cancer faster.